Literature DB >> 20208051

Probiotics.

Nancy Toedter Williams1.   

Abstract

PURPOSE: The pharmacology, uses, dosages, safety, drug interactions, and contraindications of probiotics are reviewed.
SUMMARY: Probiotics are live nonpathogenic microorganisms administered to improve microbial balance, particularly in the gastrointestinal tract. They consist of Saccharomyces boulardii yeast or lactic acid bacteria, such as Lactobacillus and Bifidobacterium species, and are regulated as dietary supplements and foods. Probiotics exert their beneficial effects through various mechanisms, including lowering intestinal pH, decreasing colonization and invasion by pathogenic organisms, and modifying the host immune response. Probiotic benefits associated with one species or strain do not necessarily hold true for others. The strongest evidence for the clinical effectiveness of probiotics has been in the treatment of acute diarrhea, most commonly due to rotavirus, and pouchitis. More research is needed to clarify the role of probiotics for preventing antibiotic-associated diarrhea, Clostridium difficile infection, travelers' diarrhea, irritable bowel syndrome, ulcerative colitis, Crohn's disease, and vulvovaginal candidiasis. There is no consensus about the minimum number of microorganisms that must be ingested to obtain a beneficial effect; however, a probiotic should typically contain several billion microorganisms to increase the chance that adequate gut colonization will occur. Probiotics are generally considered safe and well tolerated, with bloating and flatulence occurring most frequently. They should be used cautiously in patients who are critically ill or severely immunocompromised or those with central venous catheters since systemic infections may rarely occur. Bacteria-derived probiotics should be separated from antibiotics by at least two hours.
CONCLUSION: Probiotics have demonstrated efficacy in preventing and treating various medical conditions, particularly those involving the gastrointestinal tract. Data supporting their role in other conditions are often conflicting.

Entities:  

Mesh:

Year:  2010        PMID: 20208051     DOI: 10.2146/ajhp090168

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  93 in total

1.  Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans.

Authors:  Stéphanie Blanquet-Diot; Sylvain Denis; Sandrine Chalancon; Fehd Chaira; Jean-Michel Cardot; Monique Alric
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

2.  Probiotics improve survival of septic rats by suppressing conditioned pathogens in ascites.

Authors:  Da-Quan Liu; Qiao-Ying Gao; Hong-Bin Liu; Dong-Hua Li; Shang-Wei Wu
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

3.  Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection.

Authors:  Nuntra Suwantarat; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

Review 4.  Which CAM modalities are worth considering?

Authors:  Roger Zoorob; Sangita Chakrabarty; Heather O'Hara; Courtney Kihlberg
Journal:  J Fam Pract       Date:  2014-10       Impact factor: 0.493

Review 5.  Hidden Causes of Anaphylaxis.

Authors:  Vivian C Nanagas; James L Baldwin; Keerthi R Karamched
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

6.  The use of fluorescent techniques in combination with flow cytometry for fast counting of Bifidobacterium longum ATCC BAA-2753 in BIFICO capsule.

Authors:  Yuan Gao; Hong-Jing Yu; Bin Wen
Journal:  Food Sci Biotechnol       Date:  2018-05-23       Impact factor: 2.391

Review 7.  Bugs or drugs: are probiotics safe for use in the critically ill?

Authors:  Lindsay M Urben; Jennifer Wiedmar; Erica Boettcher; Rodrigo Cavallazzi; Robert G Martindale; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 8.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

9.  Effects of synbiotic supplementation on energy and macronutrients homeostasis and muscle wasting of critical care patients: study protocol and a review of previous studies.

Authors:  Najmeh Seifi; Mohammad Safarian; Mohsen Nematy; Reza Rezvani; Majid Khadem-Rezaian; Alireza Sedaghat
Journal:  Trials       Date:  2020-02-24       Impact factor: 2.279

10.  Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea.

Authors:  Elizabeth Nicole Sizemore; Kenya Maria Rivas; Jose Valdes; Joshua Caballero
Journal:  BMJ Case Rep       Date:  2012-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.